BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 546589)

  • 41. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
    Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
    Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-affinity 3H-dopamine receptors (D3 sites) in human and rat brain.
    List S; Titeler M; Seeman P
    Biochem Pharmacol; 1980 Jun; 29(11):1621-2. PubMed ID: 7396995
    [No Abstract]   [Full Text] [Related]  

  • 45. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 46. High affinity dopamine receptors (D3) in rat brain.
    Titeler M; List S; Seeman P
    Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
    [No Abstract]   [Full Text] [Related]  

  • 47. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I; Sibley DR; Leff SE
    Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.